{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T08:04:36Z","timestamp":1768550676133,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jocn.2022.09.017","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T18:56:46Z","timestamp":1665514606000},"page":"20-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association between a prior cancer history and prognosis in adult patients with high\u2011grade glioma"],"prefix":"10.1016","volume":"106","author":[{"given":"Dongjie","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peiwen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaiyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siying","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuju","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jocn.2022.09.017_b0005","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/CM9.0000000000001474","article-title":"Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020","volume":"134","author":"Cao","year":"2021","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.jocn.2022.09.017_b0010","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1002\/cncr.30164","article-title":"Risk of second primary malignancies among cancer survivors in the United States, 1992 through 2008","volume":"122","author":"Donin","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2022.09.017_b0015","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Gittleman H, Liao P, Rouse C, Chen Y, Dowling J, et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007\u20132011. Neuro Oncol 2014;16:iv1\u201363. https:\/\/doi.org\/10\/gj3td6.","DOI":"10.1093\/neuonc\/nou223"},{"key":"10.1016\/j.jocn.2022.09.017_b0020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/biomedicines9030324","article-title":"Current FDA-approved therapies for high-grade malignant gliomas","volume":"9","author":"Fisher","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jocn.2022.09.017_b0025","first-page":"1","article-title":"Comparison of dosimetric gains provided by intensity-modulated radiotherapy, volume-modulated arc therapy, and helical tomotherapy for high-grade glioma","volume":"2020","author":"Liu","year":"2020","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jocn.2022.09.017_b0030","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11060-015-2028-2","article-title":"The role of temozolomide in the management of patients with newly diagnosed anaplastic astrocytoma: a comparison of survival in the era prior to and following the availability of temozolomide","volume":"127","author":"Strowd","year":"2016","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0035","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10549-021-06122-w","article-title":"Survival of women diagnosed with breast cancer and who have survived a previous cancer","volume":"187","author":"Pruitt","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.jocn.2022.09.017_b0040","doi-asserted-by":"crossref","first-page":"4752","DOI":"10.1002\/cam4.4036","article-title":"Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer","volume":"10","author":"Pruitt","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/j.jocn.2022.09.017_b0045","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s11060-017-2469-x","article-title":"A phase II trial of arsenic trioxide and temozolomide in combination with radiation therapy for patients with malignant gliomas","volume":"133","author":"Kumthekar","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0050","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1038\/bjc.2014.209","article-title":"Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma","volume":"110","author":"Hottinger","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jocn.2022.09.017_b0055","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11060-017-2558-x","article-title":"NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients","volume":"137","author":"Ali","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0060","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11060-019-03223-x","article-title":"Phase II study of weekly carboplatin in pretreated adult malignant gliomas","volume":"144","author":"Villani","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0065","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1186\/s12885-019-5744-8","article-title":"Effect of prior cancer on survival outcomes for patients with pancreatic adenocarcinoma: a propensity score analysis","volume":"19","author":"He","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jocn.2022.09.017_b0070","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.ejso.2021.02.007","article-title":"Impact of prior cancer history on survival of patients with gastric cancer","volume":"47","author":"Wen","year":"2021","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0075","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oraloncology.2019.01.023","article-title":"Effect of prior cancer on trial eligibility and treatment outcomes in nasopharyngeal carcinoma: Implications for clinical trial accrual","volume":"90","author":"Wang","year":"2019","journal-title":"Oral Oncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0080","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s11060-019-03313-w","article-title":"Association between extent of resection on survival in adult brainstem high-grade glioma patients","volume":"145","author":"Doyle","year":"2019","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0085","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1186\/s12885-020-07634-2","article-title":"Impact of prior cancer history on the survival of patients with larynx cancer","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jocn.2022.09.017_b0090","doi-asserted-by":"crossref","unstructured":"Zhou H, Zhang Y, Liu J, Fang W, Yang Y, Hong S, et al. Impact of prior cancer on outcomes in nasopharyngeal carcinoma. Ann Transl Med 2019;7:299\u2013299. https:\/\/doi.org\/10\/gpmz7s.","DOI":"10.21037\/atm.2019.05.78"},{"key":"10.1016\/j.jocn.2022.09.017_b0095","article-title":"The risk of heart disease-related death among anaplastic astrocytoma patients after chemotherapy: a SEER population-based analysis","volume":"12","author":"Lin","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0100","article-title":"Association between preadmission metformin use and outcomes in intensive care unit patients with sepsis and type 2 diabetes: a cohort study","volume":"8","author":"Yang","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.jocn.2022.09.017_b0105","doi-asserted-by":"crossref","unstructured":"Lin J, Bytnar JA, Theeler BJ, McGlynn KA, Shriver CD, Zhu K. Survival among glioma patients in the U.S. Military Health System: a comparison with patients in the surveillance, epidemiology, and end results (SEER) Program. Cancer 2020;126:3053\u201360. https:\/\/doi.org\/10\/gpmx5c.","DOI":"10.1002\/cncr.32884"},{"key":"10.1016\/j.jocn.2022.09.017_b0110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1093\/neuonc\/noab199","article-title":"Importance of the intersection of age and sex to understand variation in incidence and survival for primary malignant gliomas","volume":"24","author":"Wang","year":"2022","journal-title":"Neuro-Oncology"},{"key":"10.1016\/j.jocn.2022.09.017_b0115","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1177\/2050640618765505","article-title":"The impact of a history of cancer on pancreatic ductal adenocarcinoma survival","volume":"6","author":"He","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1016\/j.jocn.2022.09.017_b0120","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1007\/s10620-019-05917-8","article-title":"Prognosis of hepatocellular carcinoma among cancer survivors with other types of primary tumors","volume":"65","author":"Bian","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jocn.2022.09.017_b0125","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1158\/1055-9965.EPI-18-0098","article-title":"Proportion of U.S. Trends in breast cancer incidence attributable to long-term changes in risk factor distributions","volume":"27","author":"Pfeiffer","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jocn.2022.09.017_b0130","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/ijc.30922","article-title":"Meta-analysis of the association between dietary inflammatory index (DII) and cancer outcomes","volume":"141","author":"Fowler","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jocn.2022.09.017_b0135","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1002\/cncr.10536","article-title":"Clinical trial participation among patients enrolled in the Glioma Outcomes Project","volume":"94","author":"Chang","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jocn.2022.09.017_b0140","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1080\/00207454.2018.1538989","article-title":"Prior malignancy impact on survival outcomes of glioblastoma multiforme; population-based study","volume":"129","author":"Al-Husseini","year":"2019","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.jocn.2022.09.017_b0145","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.21037\/gs-20-880","article-title":"Impact of prior cancer history on outcomes in thymoma: a propensity score, population-based study","volume":"10","author":"Wu","year":"2021","journal-title":"Gland Surg"},{"key":"10.1016\/j.jocn.2022.09.017_b0150","doi-asserted-by":"crossref","first-page":"792","DOI":"10.6004\/jnccn.2022.7017","article-title":"Potential impact of revised NCI eligibility criteria guidance: prior malignancy exclusion in breast cancer clinical trials","volume":"20","author":"Perez","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.jocn.2022.09.017_b0155","article-title":"Impact of prior cancer on the prognosis of patients with laryngeal cancer: a population-based study using the surveillance, epidemiology, and end results database","volume":"10","author":"Chen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0160","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2021\/3375297","article-title":"Research on effectiveness of prior cancer on survival outcomes for patients with nonmetastatic triple-negative breast cancer: a competing risk analysis and propensity score matching analysis of the SEER database","volume":"2021","author":"Chen","year":"2021","journal-title":"J Oncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0165","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11060-015-1793-2","volume":"123","author":"Burri","year":"2015","journal-title":"J Neurooncol"},{"key":"10.1016\/j.jocn.2022.09.017_b0170","doi-asserted-by":"crossref","first-page":"505","DOI":"10.4143\/crt.2019.421","article-title":"Concurrent and adjuvant temozolomide for newly diagnosed grade III gliomas without 1p\/19q Co-deletion: a randomized, open-label, phase 2 study (KNOG-1101 Study)","volume":"52","author":"Hwang","year":"2020","journal-title":"Cancer Res Treat"},{"key":"10.1016\/j.jocn.2022.09.017_b0175","doi-asserted-by":"crossref","first-page":"552","DOI":"10.4143\/crt.2019.210","article-title":"Impact of prior cancer history on the clinical outcomes in advanced breast cancer: a propensity score-adjusted, Population-Based Study","volume":"52","author":"Lin","year":"2020","journal-title":"Cancer Res Treat"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822003782?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586822003782?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T21:31:14Z","timestamp":1760823074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586822003782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":35,"alternative-id":["S0967586822003782"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2022.09.017","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between a prior cancer history and prognosis in adult patients with high\u2011grade glioma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2022.09.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}